Trial intelligence / Profile preview

Laser Treatment for Onychomycosis in Diabetics

NCT02019446Unknown

Sponsor
BCDiabetes
Start
Jul 2018
Primary completion
Dec 2020
Countries
1
01

Overview

Randomised, open-label trial (2 arms), sponsored by BCDiabetes. Primary endpoints: Proportion of participants with microbiological cure at 6 months and Safety outcomes (side effects) at 6 months. Status: unknown.

Beyond the preview

Go deeper on NCT02019446.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02019446.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call